Teens Buying Nicotine Pouches on Social Media Raises Doubt on Legality in Australia

Regulations by 2FIRSTS.ai
Apr.23.2024
Teens Buying Nicotine Pouches on Social Media Raises Doubt on Legality in Australia
Mamamia reports, nicotine pouch products such as Velo from British American Tobacco are targeting youth on social media platforms.

According to a report by Mamamia, many nicotine pouch products are being promoted to teenagers on social media platforms such as TikTok and Instagram. Given the rapid increase in teenage e-cigarette use in recent years and the implementation of regulations that make it difficult for teenagers to access e-cigarette products, it is not surprising that the tobacco industry is introducing more products to maintain its future revenue stream.

 

Several multinational tobacco companies, including Philip Morris International and British American Tobacco, are producing nicotine pouches. British American Tobacco's nicotine pouch brand Velo is also a major sponsor of the McLaren Formula One racing team. But are these nicotine pouches considered legal in Australia?

 

Nicotine pouches are similar to another product called snus, but they contain different ingredients. These products are sold in many countries around the world, and sales have been increasing rapidly among young people. These small pouches, like tea bags, are placed between the lip and gum. They are typically contained in small, colorful cans, with each can containing 15 to 20 pouches. Although they do not contain tobacco, they do contain nicotine extracted from tobacco or synthetically created. They come in a variety of flavors and strengths.

 

Nicotine pouches, in addition to nicotine, often contain plant fibers (used as a tobacco substitute as filler and to maintain the shape of the pouch), sweeteners, and various flavors. Similar to e-cigarette products, there are a wide variety of options available, including various fruit flavors, candy flavors, spice flavors, and beverage flavors. The appealing flavors and the possibility of discreet use may make nicotine pouches especially popular among young people.

 

Users inhale the nicotine from the pouch in their mouth and replace it with a new one once all the nicotine has been absorbed. Nicotine pouches without tobacco are a relatively new product, but similar products containing tobacco, such as snus, have been popular in Scandinavian countries, especially Sweden, for decades. However, snus and nicotine pouches are two different products. Due to the tobacco content in snus and the absence of it in nicotine pouches, the regulations governing these two products in Australia are completely different.

 

In order to clarify legislative content, tobacco-containing small pouches like snus have been banned from sale in Australia since 1991 as part of the prohibition on all forms of smokeless tobacco consumption. This also means that in Australia, other smokeless tobacco products such as chewing tobacco, nasal snuff, and dissolvable tobacco sticks or strips are also prohibited from being sold. General retailers like tobacco shops and convenience stores are also unable to legally sell smokeless nicotine pouches in Australia.

 

The reasons for prohibition are more complex, as Australia's Poison Standard dictates that nicotine is a prescription-only medication, with only two exceptions. Nicotine can be used in prepared tobacco and packaging for cigarettes and cigars, or as a therapeutic aid for smoking cessation, such as nicotine patches, gum, mouth spray, and lozenges. If a nicotine-containing product does not meet these two exceptions, it cannot be legally sold by general retailers. Currently, nicotine pouches have not been approved by the Therapeutic Goods Administration as a viable treatment method for smoking cessation, so overall, they are not legally sold in Australia.

 

However, if users have a prescription from a healthcare professional, nicotine pouches can be legally imported and used for personal use. We only have some rumors about the use of nicotine pouches and no concrete data, as these products are still relatively new in Australia. But we do know that relevant authorities are increasing efforts to seize these products. Clearly, young people using nicotine pouches are unlikely to obtain them through legal means.

 

Even in this situation, nicotine remains a cause for concern. Some of the potential effects of nicotine exposure include dizziness, headaches, nausea, and stomach pain, especially in those who do not regularly smoke or use e-cigarettes. While we do not yet have long-term data on the health effects of nicotine pouches, we know that nicotine is addictive and harmful to health. For example, it can lead to cardiovascular issues, particularly at higher doses such as irregular heart rhythms. It may also have negative effects on the brain development of adolescents.

 

Some nicotine pouches on the market are alarmingly high in nicotine content. Some brands offer pouches with over 10mg of nicotine, which is comparable to the nicotine content of a cigarette. A report from the World Health Organization indicates that this level of nicotine content is sufficient to induce and sustain nicotine addiction.

 

Nicotine pouches are also marketed as a product to use when you cannot use e-cigarettes or smoke, such as on airplanes. Therefore, rather than saying they can help people quit smoking, it is better to view them as an alternative to smoking and using e-cigarettes. Importantly, there is no clear evidence that pouches are an effective aid for quitting smoking or stopping the use of e-cigarettes. In addition, some nicotine pouches, although tobacco-free products, still contain specific tobacco-specific nitrosamines. These compounds can damage DNA and may lead to cancer after long-term exposure.

 

Overall, due to the relatively short time that nicotine pouches have been on the market, there is still limited specific data on their health harms. However, given their similarity to smokeless tobacco products, the World Health Organization recommends taking a cautious approach towards these products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
At the 2026 NACS Show in Las Vegas, JTI Liggett highlighted its value-priced cigarette portfolio, including LD and Montego, following JT Group's acquisition of Vector Group. The company's U.S. business reported market share gains, with LD sales volume rising 32.6% in the first half of 2026. Meanwhile, Ploom was displayed separately at Altria's booth under an existing partnership. JTI Liggett booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States.
EXPO
Oct.09
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
UK vape brand IVG has launched the NEXiO reusable prefilled pod system, expanding its product portfolio beyond disposable vape products. The device features a 1,000mAh rechargeable battery, prefilled pods with a refill reservoir structure and a claimed capacity of up to 10,000 puffs. Officially launched in the UK on July 9, 2026, NEXiO debuted with 17 flavor options, reflecting IVG’s move into reusable pod formats.
Aug.19
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
Korea Customs Service has tightened import controls on nicotine-analog and nicotine-free e-cigarette liquids, placing the products under 100% document review and subjecting all e-cigarette liquid import declarations to pre-clearance ingredient analysis. As of September 20, 2026, South Korea had imported about 15 metric tons of nicotine-analog liquids, 99.99% from China, and about 316 metric tons of nicotine-free liquids, including roughly 315 metric tons, or 99.7%, from China. The measures follow South Korea's April expansion of its tobacco definition to include synthetic nicotine products and include new checks on Chinese manufacturing, transaction and export documentation.
Sep.24